ACQUISITIONS (Tables)

12 Months Ended

Dec. 31, 2020

Schedule Of Business Acquisitions, Asana Hospice

The Company has finalized its valuation of the assets acquired and liabilities assumed. The total estimated consideration of $65.6 million has been allocated to assets acquired and liabilities assumed as of the acquisition date as follows (amounts in millions):


	Amount
Patient accounts receivable	$	4.6
Property and equipment	0.2
Operating lease right of use assets	0.9
Intangible assets	5.6
Total assets acquired	11.3
Accounts payable	(3.2)
Payroll and employee benefits	(1.5)
Accrued expenses	(0.5)
Operating lease liabilities	(0.9)
Total liabilities assumed	(6.1)
Net identifiable assets acquired	5.2
Goodwill	60.4
Total estimated consideration	$	65.6

Schedule Of Business Acquisitions, AseraCare Hospice

The Company is in the process of reviewing the fair value of the assets acquired and liabilities assumed. During the year ended December 31, 2020, we recorded measurement period adjustments based on changes to management's estimates and assumptions related to the assets acquired and liabilities assumed. The final valuation of the assets acquired and liabilities assumed was not complete as of December 31, 2020, but will be finalized within the allowable measurement period. Based on the Company's preliminary valuation, the total estimated consideration of $229.6 million has been allocated to assets acquired and liabilities assumed as of the acquisition date as follows (amounts in millions):


	Amount
Patient accounts receivable	$	15.0
Prepaid expenses	0.7
Property and equipment	0.6
Operating lease right of use assets	5.9
Intangible assets	24.3
Other assets	0.1
Total assets acquired	46.6
Accounts payable	(5.8)
Payroll and employee benefits	(5.9)
Accrued expenses	(10.4)
Operating lease liabilities	(5.4)
Total liabilities assumed	(27.5)
Net identifiable assets acquired	19.1
Goodwill	210.5
Total estimated consideration	$	229.6

Schedule of Pro Forma Financial Information, AseraCare

The following table contains unaudited pro forma condensed consolidated statement of operations information for the years ended December 31, 2020 and 2019 assuming that the AseraCare acquisition closed on January 1, 2019 (amounts in millions, except per share data). The pro forma financial information includes various assumptions, including those related to the preliminary purchase price allocation of assets acquired and liabilities assumed. The pro forma financial information may vary in future quarters based on the final valuations and analysis of the fair value of the assets acquired and liabilities assumed.


	For the Years Ended December 31,
	2020		2019
Net service revenue	$	2,120.1	$	2,077.0
Operating income	218.0		167.5
Net income attributable to Amedisys Inc.	180.6		112.3
Basic earnings per share	5.55		3.49
Diluted earnings per share	5.43		3.40

Schedule Of Business Acquisitions Compassionate Care Hospice

The Company has finalized its valuation of the assets acquired and liabilities assumed. The total consideration of $327.9 million has been allocated to assets acquired and liabilities assumed as of the acquisition date as follows (amounts in millions):


	Amount
Patient accounts receivable	$	24.5
Prepaid expenses	0.8
Other current assets	0.1
Property and equipment	0.2
Intangible assets	27.2
Operating lease right of use assets	3.4
Other assets	1.1
Total assets acquired	57.3
Accounts payable	(14.9)
Payroll and employee benefits	(11.7)
Accrued expenses	(11.7)
Deferred tax liability	(0.9)
Operating lease liabilities	(3.4)
Total liabilities acquired	(42.6)
Net identifiable assets acquired	14.7
Goodwill	313.2
Total estimated consideration	$	327.9

Schedule of Pro Forma Financial Information, Compassionate Care Hospice

The following table contains unaudited pro forma condensed consolidated statement of operations information for the years ended December 31, 2019 and 2018 assuming that the CCH acquisition closed on January 1, 2018 (amounts in millions, except per share data):


	For the Years Ended December 31,
	2019		2018
Net service revenue	$	1,971.7	$	1,852.8
Operating income	183.8		175.7
Net income attributable to Amedisys, Inc.	130.5		124.6
Basic earnings per share	4.06		3.80
Diluted earnings per share	$	3.96	$	3.71